Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Receives Confirmation of 5-year Patent Term Extension of U.S. Patent for Latanoprostene Bunod, Commercialized as VYZULTA®

January 31, 2024

View Press Release Corporate presentation Contact us
Previous